Stock HEALTH NIGHTINGALE HEALTH OYJ
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Nightingale Health Oyj

Equities

HEALTH

FI4000490875

Market Closed - Nasdaq Helsinki
Other stock markets
 08:59:43 26/04/2024 pm IST 		5-day change 1st Jan Change
1.86 EUR -4.37% Intraday chart for Nightingale Health Oyj +18.47% +66.67%
16/04 Finland’s Nightingale Health Plots US Expansion MT
16/04 Nightingale Health to Establish A Laboratory in the United States CI

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • Based on current prices, the company has particularly high valuation levels.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
NIGHTINGALE HEALTH OYJ Stock Nightingale Health Oyj
+66.67% 120M -
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+4.36% 32.47B
C
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+14.14% 7.45B
C-
SECTRA AB Stock Sectra AB
+22.93% 3.89B
B-
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-16.29% 3.17B
C-
OMNICELL, INC. Stock Omnicell, Inc.
-25.96% 1.28B
B
LUNIT INC. Stock Lunit Inc.
-36.14% 1.09B -
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-35.42% 902M -
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
-0.13% 893M
C
VERADIGM INC. Stock Veradigm Inc.
-24.12% 857M -
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. HEALTH Stock
  4. Ratings Nightingale Health Oyj